Insider · CIK 0001943326
Doug Samuelson
Files at KAPA (Kairos Pharma, LTD.). First filing Nov 25, 2024, latest Nov 25, 2024.
In brief
Doug Samuelson files SEC Form 4 as CFO at KAPA (Kairos Pharma, LTD.). Since Nov 25, 2024, Doug Samuelson has reported 1 open-market buy worth $3,750 and 0 open-market sells worth $0, the latest filed on Nov 25, 2024.
A track record needs three past buys with six months of prices behind them; Doug Samuelson has 0, so none is measured yet.
The newest scored trade: bought $3,750 of KAPA on Nov 22, 2024, filed Nov 25, 2024, scored 37 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KAPA: Kairos Pharma, LTD.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | KAPA Kairos Pharma, LTD. | AGrant or award COMMON STOCK | +152,672 | $0.00 | $0 | 293,039 | Nov 26, 2025 |
| Nov 22, 2024 | KAPA Kairos Pharma, LTD. | POpen-market purchase COMMON STOCK | +2,500 | $1.50 | $3,750 | 60,796 | Nov 25, 2024 |
Questions about Doug Samuelson
Answered from the filings on this page, as of the latest one.
Is Doug Samuelson buying or selling?
Not in the last 12 months. Doug Samuelson's latest open-market trade on SEC Form 4 was bought $3,750 of KAPA on Nov 22, 2024.
How did Doug Samuelson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Doug Samuelson has 0.
Where does Doug Samuelson file Form 4?
Doug Samuelson has filed Form 4 at KAPA (Kairos Pharma, LTD.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.